| abstract |
in one aspect, the disclosure provides compounds (ii), compositions and methods for administering the compounds and compositions to a patient who needs them. in another aspect, the disclosure refers to compounds and compositions for treating cancer, for example, lymphoid leukemia. the disclosure further provides compounds that inhibit two isoforms of phosphoinositide-3-kinase (pi3k), ¿ed, pharmaceutical compositions comprising said compounds and methods for using said compounds and said pharmaceutical compositions for treatment, improvement, and / or prevention of non-hodgkin's lymphoma. |